The 2,5-diketopiperazines structurally related to the thyrotropin-releasing hormone have been reported to prevent or reduce both necrotic and apoptotic cell death in different in vitro models and to reduce lesion volumes and improve cognitive and motor outcomes in rodent models of traumatic brain injury [68,69,70,71]. This evidence concerns the gene TRH and brain injury.